Name: Corvus Pharmaceuticals, Inc. (CRVS) Balance Sheet
Creator: FinSpry

Corvus Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Corvus Pharmaceuticals, Inc. (CRVS) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	8.74	27.15	13.16	69.45	16.46	77.98	114.60
Short-Term Investments	43.22	14.53	29.14	5.99	27.80	0.00	0.00
Cash & Short-Term Investments	51.96	27.15	42.30	69.45	44.26	77.98	114.60
Accounts Receivable	0.22	0.03	0.59	0.51	0.09	0.00	0.34
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.47	12.82	0.10	12.50	0.40	1.89	0.27
Total Current Assets	54.41	27.96	43.66	71.31	45.34	79.34	115.59
Non-Current Assets
Property, Plant & Equipment (Net)	1.33	1.39	2.57	3.65	2.55	3.76	2.18
Long-Term Investments	12.54	16.12	21.88	34.27	37.23	0.00	0.00
Other Non-Current Assets	0.63	0.09	0.13	0.24	0.41	0.51	0.46
Total Non-Current Assets	14.50	17.60	24.58	38.15	40.15	4.28	2.64
Total Assets	68.91	45.55	68.24	109.46	85.53	83.62	118.23
Current Liabilities
Accounts Payable	2.58	5.50	1.98	1.57	3.47	2.45	7.03
Short-Term Debt	0.19	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	3.44	3.73	6.28	5.11	7.42	0.00	0.00
Other Current Liabilities	29.20	3.97	0.16	7.08	0.18	0.00	0.00
Total Current Liabilities	35.40	6.87	10.75	9.69	12.15	3.33	7.03
Non-Current Liabilities
Long-Term Debt	0.94	0.00	1.37	2.60	1.23	2.31	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.94	0.00	1.37	2.60	1.23	2.31	0.87
Total Liabilities	36.34	6.87	12.13	12.29	13.38	5.64	7.90
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.00	0.00	0.00
Retained Earnings	-397.01	-335.68	-307.69	-264.51	-223.14	-217.15	-170.47
Accumulated Other Comprehensive Income	-1.29	-0.97	-0.56	1.87	0.00	0.03	-0.03
Additional Paid-in Capital	430.86	374.36	364.36	361.67	295.28	288.22	280.84
Shares Outstanding	67.90	49.04	46.55	46.55	0.00	0.00	0.00
Total Stockholders' Equity	32.57	38.68	56.12	97.16	72.15	71.11	110.34
Total Liabilities & Equity	68.91	45.55	68.24	109.46	85.53	83.62	118.23